Over 250 thought leaders gathered at the San Francisco Fairmont
Hotel on January 29-30, 2004, to discuss the latest technologies
and applications in high-content analysis. The level of energy
and participation reflected the booming interest in this
evolving field. Many delegates commented that this was the
largest gathering of HCS professionals at a dedicated meeting.
CHI would like to thank the scientific advisors, sponsors, and
all of the participants for making this meeting a success!
To get a better feel for energetic atmosphere at the meeting,
please take a look at the attendees’ comments and the
photo
gallery.
|
 |
| While we can't make up for the missed networking opportunities,
we can offer you access to a complete set of conference
proceedings, including 25 slide presentations from the leading
pharmaceutical researchers (Click here to view the agenda) and
26 posters, most include full PDFs. Only $300 gets you online
access to this information.
Click here to subscribe
|
|
 |
We are also pleased to announce:
High-Content Analysis 2005
January 25-27, San Francisco, CA.
Please contact:
Julia Boguslavsky, Conference Director
with any questions or suggestions.
Click here to view additional
Photos |
|
|
High-Content Analysis
2004 |
Subscribe to Conference Proceedings
Missed the conference?
Only $300 gets you access to:
- 25 Slide Presentations
- 26
Posters
- Articles from Leading Drug Discovery News Sources
| Delegates'
Comments: |
| "An excellent
opportunity to hear the key players talk about key
aspects of HCS." |
|
Dr.
Anthony Holmes
Business Development
Image Metrics |
| |
| "CHI has done a
brilliant job in bringing together the most relevant
opinion makers, vendors and users for a first ever
meeting in a cutting-edge field." |
|
Bill
Baumbach
Director Drug R&D
X Cell Medical, Inc. |
| |
| "This is the first
independently organized meeting focusing on high content
screening and is a prime example of the proliferation of
HCS into all aspects of drug discovery and systems
biology." |
|
Judy
P. Masucci
Director of Marketing
Cellomics, Inc. |
| |
| "The easy drug
targets have been done! For the future challenge we will
need even higher content screening methods." |
|
Ron
Koop
Head of Biological Research
MelTec GmbH |
| |
| "This conference
was very informative, it gave me the breath and the
depth of HCS today and where it is going in the future." |
|
Hemchand Sookdeo
Assocaite Director
Wyeth |
|
|
|
"The Most informative
conference I've attended!" |
|
Seungtaek Lee
Biochemist
Merck & Co. |
|
